nodes	percent_of_prediction	percent_of_DWPC	metapath
Galantamine—BCHE—Terbutaline—asthma	0.145	0.259	CbGbCtD
Galantamine—BCHE—Triamcinolone—asthma	0.0373	0.0665	CbGbCtD
Galantamine—CYP2D6—Ciclesonide—asthma	0.0241	0.043	CbGbCtD
Galantamine—CYP2D6—Ipratropium bromide—asthma	0.02	0.0356	CbGbCtD
Galantamine—CYP3A4—Fluticasone furoate—asthma	0.0188	0.0335	CbGbCtD
Galantamine—CYP2D6—Zafirlukast—asthma	0.0176	0.0314	CbGbCtD
Galantamine—CYP2D6—Arformoterol—asthma	0.017	0.0303	CbGbCtD
Galantamine—CYP2D6—Formoterol—asthma	0.017	0.0303	CbGbCtD
Galantamine—CYP3A4—Budesonide—asthma	0.0168	0.0299	CbGbCtD
Galantamine—CYP3A4—Ciclesonide—asthma	0.0153	0.0273	CbGbCtD
Galantamine—CYP3A4—Indacaterol—asthma	0.0153	0.0273	CbGbCtD
Galantamine—CYP2D6—Tiotropium—asthma	0.0151	0.027	CbGbCtD
Galantamine—CYP3A4—Salmeterol—asthma	0.0142	0.0254	CbGbCtD
Galantamine—CYP3A4—Salbutamol—asthma	0.0142	0.0254	CbGbCtD
Galantamine—CYP3A4—Flunisolide—asthma	0.0142	0.0254	CbGbCtD
Galantamine—CYP2D6—Theophylline—asthma	0.0136	0.0242	CbGbCtD
Galantamine—CYP2D6—Loratadine—asthma	0.0129	0.023	CbGbCtD
Galantamine—CYP3A4—Ipratropium bromide—asthma	0.0127	0.0227	CbGbCtD
Galantamine—CYP3A4—Zileuton—asthma	0.0127	0.0227	CbGbCtD
Galantamine—CYP3A4—Fluticasone Propionate—asthma	0.0121	0.0216	CbGbCtD
Galantamine—CYP3A4—Zafirlukast—asthma	0.0112	0.0199	CbGbCtD
Galantamine—CYP3A4—Tiotropium—asthma	0.00962	0.0172	CbGbCtD
Galantamine—CYP3A4—Aminophylline—asthma	0.00918	0.0164	CbGbCtD
Galantamine—CYP3A4—Theophylline—asthma	0.00863	0.0154	CbGbCtD
Galantamine—CYP3A4—Montelukast—asthma	0.00818	0.0146	CbGbCtD
Galantamine—CYP3A4—Loratadine—asthma	0.00818	0.0146	CbGbCtD
Galantamine—CYP3A4—Methylprednisolone—asthma	0.00748	0.0134	CbGbCtD
Galantamine—BCHE—diaphragm—asthma	0.00704	0.123	CbGeAlD
Galantamine—CYP3A4—Triamcinolone—asthma	0.00567	0.0101	CbGbCtD
Galantamine—CHRNA4—autonomic nervous system—asthma	0.00546	0.0956	CbGeAlD
Galantamine—CYP3A4—Betamethasone—asthma	0.00487	0.00868	CbGbCtD
Galantamine—CYP3A4—Prednisolone—asthma	0.0048	0.00857	CbGbCtD
Galantamine—CYP3A4—Hydrocortisone—asthma	0.00455	0.00812	CbGbCtD
Galantamine—CYP3A4—Prednisone—asthma	0.00453	0.00809	CbGbCtD
Galantamine—CYP2D6—Dexamethasone—asthma	0.00445	0.00794	CbGbCtD
Galantamine—CHRND—respiratory system—asthma	0.00293	0.0513	CbGeAlD
Galantamine—CYP3A4—Dexamethasone—asthma	0.00283	0.00505	CbGbCtD
Galantamine—CHRNG—trachea—asthma	0.00273	0.0477	CbGeAlD
Galantamine—CHRND—cardiovascular system—asthma	0.00224	0.0393	CbGeAlD
Galantamine—CHRNA3—respiratory system—asthma	0.00218	0.0382	CbGeAlD
Galantamine—CHRNB4—adrenal gland—asthma	0.00215	0.0377	CbGeAlD
Galantamine—CHRNG—lung—asthma	0.00196	0.0343	CbGeAlD
Galantamine—CHRNB2—adrenal cortex—asthma	0.00189	0.033	CbGeAlD
Galantamine—CHRNB2—bronchus—asthma	0.00185	0.0324	CbGeAlD
Galantamine—CHRNB2—smooth muscle tissue—asthma	0.00181	0.0317	CbGeAlD
Galantamine—CHRFAM7A—respiratory system—asthma	0.00176	0.0309	CbGeAlD
Galantamine—CHRNB2—trachea—asthma	0.00166	0.0291	CbGeAlD
Galantamine—CHRND—lung—asthma	0.00155	0.0272	CbGeAlD
Galantamine—CHRNA4—respiratory system—asthma	0.00141	0.0246	CbGeAlD
Galantamine—CHRNB2—adrenal gland—asthma	0.00136	0.0239	CbGeAlD
Galantamine—CHRNA3—adrenal gland—asthma	0.00132	0.0231	CbGeAlD
Galantamine—CHRFAM7A—trachea—asthma	0.0013	0.0228	CbGeAlD
Galantamine—CHRNB2—lung—asthma	0.00119	0.0209	CbGeAlD
Galantamine—CHRNA3—lung—asthma	0.00116	0.0203	CbGeAlD
Galantamine—CHRNA4—bronchus—asthma	0.00116	0.0202	CbGeAlD
Galantamine—CHRNB1—adrenal gland—asthma	0.00114	0.02	CbGeAlD
Galantamine—CHRNA7—cardiovascular system—asthma	0.00109	0.0191	CbGeAlD
Galantamine—CHRNA4—cardiovascular system—asthma	0.00108	0.0188	CbGeAlD
Galantamine—ACHE—adrenal gland—asthma	0.000991	0.0173	CbGeAlD
Galantamine—CHRNA7—adrenal gland—asthma	0.000863	0.0151	CbGeAlD
Galantamine—CHRNA4—adrenal gland—asthma	0.000851	0.0149	CbGeAlD
Galantamine—BCHE—respiratory system—asthma	0.000804	0.0141	CbGeAlD
Galantamine—CHRNA4—lung—asthma	0.000746	0.0131	CbGeAlD
Galantamine—BCHE—bronchus—asthma	0.000662	0.0116	CbGeAlD
Galantamine—BCHE—smooth muscle tissue—asthma	0.000647	0.0113	CbGeAlD
Galantamine—BCHE—cardiovascular system—asthma	0.000616	0.0108	CbGeAlD
Galantamine—BCHE—trachea—asthma	0.000594	0.0104	CbGeAlD
Galantamine—BCHE—adrenal gland—asthma	0.000487	0.00853	CbGeAlD
Galantamine—BCHE—lung—asthma	0.000427	0.00747	CbGeAlD
Galantamine—CYP3A4—Estrogen metabolism—GSTM1—asthma	0.000113	0.00141	CbGpPWpGaD
Galantamine—BCHE—Transmission across Chemical Synapses—CHAT—asthma	0.000111	0.00138	CbGpPWpGaD
Galantamine—CHRNA4—SIDS Susceptibility Pathways—BDNF—asthma	0.00011	0.00137	CbGpPWpGaD
Galantamine—CHRNA4—Transmission across Chemical Synapses—ADCY2—asthma	0.00011	0.00137	CbGpPWpGaD
Galantamine—CHRNA4—Neuronal System—ALDH2—asthma	0.000109	0.00136	CbGpPWpGaD
Galantamine—CHRNA3—Neuronal System—ADCY2—asthma	0.000109	0.00136	CbGpPWpGaD
Galantamine—BCHE—Glycerophospholipid biosynthesis—PLA2G4A—asthma	0.000106	0.00132	CbGpPWpGaD
Galantamine—CHRNA4—SIDS Susceptibility Pathways—IL10—asthma	0.000105	0.00131	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—LTC4S—asthma	0.000104	0.00129	CbGpPWpGaD
Galantamine—CHRNA7—Neuronal System—ADCY2—asthma	0.000103	0.00129	CbGpPWpGaD
Galantamine—CHRNB2—SIDS Susceptibility Pathways—CXCL8—asthma	0.000103	0.00128	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—MUC7—asthma	0.000102	0.00128	CbGpPWpGaD
Galantamine—CHRNB4—SIDS Susceptibility Pathways—IL6R—asthma	0.000102	0.00127	CbGpPWpGaD
Galantamine—CHRNA1—Neuronal System—ADCY2—asthma	0.000102	0.00127	CbGpPWpGaD
Galantamine—ACHE—Transmission across Chemical Synapses—ALDH2—asthma	0.000101	0.00126	CbGpPWpGaD
Galantamine—ACHE—Monoamine Transport—TNF—asthma	0.000101	0.00126	CbGpPWpGaD
Galantamine—ACHE—Peptide hormone metabolism—LEP—asthma	0.0001	0.00125	CbGpPWpGaD
Galantamine—CHRNB2—Circadian rythm related genes—SERPINE1—asthma	9.93e-05	0.00124	CbGpPWpGaD
Galantamine—CHRNB2—SIDS Susceptibility Pathways—IL1B—asthma	9.88e-05	0.00123	CbGpPWpGaD
Galantamine—CHRNA4—SIDS Susceptibility Pathways—NR3C1—asthma	9.71e-05	0.00121	CbGpPWpGaD
Galantamine—CHRNA2—Neuronal System—ADCY2—asthma	9.71e-05	0.00121	CbGpPWpGaD
Galantamine—ACHE—ATF-2 transcription factor network—BCL2—asthma	9.67e-05	0.00121	CbGpPWpGaD
Galantamine—ACHE—ATF-2 transcription factor network—IFNG—asthma	9.59e-05	0.00119	CbGpPWpGaD
Galantamine—ACHE—Neuronal System—CHAT—asthma	9.52e-05	0.00119	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—LTC4S—asthma	9.25e-05	0.00115	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—MUC7—asthma	9.14e-05	0.00114	CbGpPWpGaD
Galantamine—BCHE—Transmission across Chemical Synapses—ALDH2—asthma	9.04e-05	0.00113	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—LTA4H—asthma	8.99e-05	0.00112	CbGpPWpGaD
Galantamine—BCHE—Peptide hormone metabolism—LEP—asthma	8.93e-05	0.00111	CbGpPWpGaD
Galantamine—ACHE—ATF-2 transcription factor network—CXCL8—asthma	8.91e-05	0.00111	CbGpPWpGaD
Galantamine—CHRNA7—SIDS Susceptibility Pathways—IL6R—asthma	8.88e-05	0.00111	CbGpPWpGaD
Galantamine—CYP2D6—Phase 1 - Functionalization of compounds—ALDH2—asthma	8.83e-05	0.0011	CbGpPWpGaD
Galantamine—CYP3A4—Tryptophan metabolism—ALDH2—asthma	8.81e-05	0.0011	CbGpPWpGaD
Galantamine—ACHE—Peptide hormone metabolism—POMC—asthma	8.6e-05	0.00107	CbGpPWpGaD
Galantamine—BCHE—Neuronal System—CHAT—asthma	8.5e-05	0.00106	CbGpPWpGaD
Galantamine—CHRNA4—Neuronal System—ADCY2—asthma	8.42e-05	0.00105	CbGpPWpGaD
Galantamine—CHRNB2—SIDS Susceptibility Pathways—VEGFA—asthma	8.37e-05	0.00104	CbGpPWpGaD
Galantamine—ACHE—Phospholipid metabolism—PLA2G4A—asthma	8.26e-05	0.00103	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—ESR2—asthma	8.25e-05	0.00103	CbGpPWpGaD
Galantamine—CHRNB4—SIDS Susceptibility Pathways—CXCL8—asthma	8.11e-05	0.00101	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—IL3—asthma	8.1e-05	0.00101	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—LTA4H—asthma	8.02e-05	0.000999	CbGpPWpGaD
Galantamine—ACHE—Transmission across Chemical Synapses—ADCY2—asthma	7.84e-05	0.000977	CbGpPWpGaD
Galantamine—CHRNB4—SIDS Susceptibility Pathways—IL1B—asthma	7.78e-05	0.00097	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—MUC5AC—asthma	7.77e-05	0.000968	CbGpPWpGaD
Galantamine—ACHE—Neuronal System—ALDH2—asthma	7.76e-05	0.000968	CbGpPWpGaD
Galantamine—BCHE—Peptide hormone metabolism—POMC—asthma	7.68e-05	0.000957	CbGpPWpGaD
Galantamine—CHRNB2—Circadian rythm related genes—PTEN—asthma	7.57e-05	0.000943	CbGpPWpGaD
Galantamine—BCHE—Phospholipid metabolism—PLA2G4A—asthma	7.37e-05	0.000918	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—NTRK1—asthma	7.29e-05	0.000908	CbGpPWpGaD
Galantamine—CHRNA4—SIDS Susceptibility Pathways—IL6R—asthma	7.24e-05	0.000902	CbGpPWpGaD
Galantamine—CHRNB2—SIDS Susceptibility Pathways—TNF—asthma	7.17e-05	0.000894	CbGpPWpGaD
Galantamine—CHRNA7—SIDS Susceptibility Pathways—CXCL8—asthma	7.04e-05	0.000877	CbGpPWpGaD
Galantamine—BCHE—Transmission across Chemical Synapses—ADCY2—asthma	6.99e-05	0.000871	CbGpPWpGaD
Galantamine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—asthma	6.98e-05	0.00087	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—MUC5AC—asthma	6.93e-05	0.000864	CbGpPWpGaD
Galantamine—BCHE—Neuronal System—ALDH2—asthma	6.93e-05	0.000863	CbGpPWpGaD
Galantamine—Vomiting—Budesonide—asthma	6.85e-05	0.000227	CcSEcCtD
Galantamine—Syncope—Hydrocortisone—asthma	6.85e-05	0.000227	CcSEcCtD
Galantamine—Angiopathy—Dexamethasone—asthma	6.8e-05	0.000225	CcSEcCtD
Galantamine—Angiopathy—Betamethasone—asthma	6.8e-05	0.000225	CcSEcCtD
Galantamine—Rash—Budesonide—asthma	6.79e-05	0.000225	CcSEcCtD
Galantamine—Dermatitis—Budesonide—asthma	6.79e-05	0.000225	CcSEcCtD
Galantamine—Convulsion—Prednisolone—asthma	6.77e-05	0.000224	CcSEcCtD
Galantamine—CHRNA7—SIDS Susceptibility Pathways—IL1B—asthma	6.75e-05	0.000842	CbGpPWpGaD
Galantamine—Headache—Budesonide—asthma	6.75e-05	0.000223	CcSEcCtD
Galantamine—Hypertension—Prednisolone—asthma	6.75e-05	0.000223	CcSEcCtD
Galantamine—Loss of consciousness—Hydrocortisone—asthma	6.71e-05	0.000222	CcSEcCtD
Galantamine—Arrhythmia—Dexamethasone—asthma	6.69e-05	0.000222	CcSEcCtD
Galantamine—Arrhythmia—Betamethasone—asthma	6.69e-05	0.000222	CcSEcCtD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—BDNF—asthma	6.67e-05	0.000831	CbGpPWpGaD
Galantamine—Ill-defined disorder—Triamcinolone—asthma	6.67e-05	0.000221	CcSEcCtD
Galantamine—Ill-defined disorder—Methylprednisolone—asthma	6.65e-05	0.00022	CcSEcCtD
Galantamine—Bradycardia—Prednisone—asthma	6.64e-05	0.00022	CcSEcCtD
Galantamine—Convulsion—Hydrocortisone—asthma	6.61e-05	0.000219	CcSEcCtD
Galantamine—Nausea—Salbutamol—asthma	6.61e-05	0.000219	CcSEcCtD
Galantamine—Hypertension—Hydrocortisone—asthma	6.59e-05	0.000218	CcSEcCtD
Galantamine—CHRNB4—SIDS Susceptibility Pathways—VEGFA—asthma	6.59e-05	0.000821	CbGpPWpGaD
Galantamine—Discomfort—Prednisolone—asthma	6.58e-05	0.000218	CcSEcCtD
Galantamine—Haemoglobin—Prednisone—asthma	6.56e-05	0.000217	CcSEcCtD
Galantamine—Haemorrhage—Prednisone—asthma	6.53e-05	0.000216	CcSEcCtD
Galantamine—Myalgia—Hydrocortisone—asthma	6.5e-05	0.000215	CcSEcCtD
Galantamine—Hallucination—Prednisone—asthma	6.49e-05	0.000215	CcSEcCtD
Galantamine—Malaise—Triamcinolone—asthma	6.48e-05	0.000215	CcSEcCtD
Galantamine—Anxiety—Hydrocortisone—asthma	6.48e-05	0.000214	CcSEcCtD
Galantamine—Malaise—Methylprednisolone—asthma	6.47e-05	0.000214	CcSEcCtD
Galantamine—Vertigo—Triamcinolone—asthma	6.46e-05	0.000214	CcSEcCtD
Galantamine—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—asthma	6.45e-05	0.000214	CcSEcCtD
Galantamine—Syncope—Triamcinolone—asthma	6.45e-05	0.000213	CcSEcCtD
Galantamine—Vertigo—Methylprednisolone—asthma	6.44e-05	0.000213	CcSEcCtD
Galantamine—Syncope—Methylprednisolone—asthma	6.43e-05	0.000213	CcSEcCtD
Galantamine—Discomfort—Hydrocortisone—asthma	6.42e-05	0.000213	CcSEcCtD
Galantamine—Connective tissue disorder—Prednisone—asthma	6.41e-05	0.000212	CcSEcCtD
Galantamine—Nausea—Budesonide—asthma	6.4e-05	0.000212	CcSEcCtD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—PLA2G4A—asthma	6.37e-05	0.000794	CbGpPWpGaD
Galantamine—Loss of consciousness—Triamcinolone—asthma	6.32e-05	0.000209	CcSEcCtD
Galantamine—Loss of consciousness—Methylprednisolone—asthma	6.3e-05	0.000209	CcSEcCtD
Galantamine—Shock—Prednisolone—asthma	6.28e-05	0.000208	CcSEcCtD
Galantamine—Cough—Triamcinolone—asthma	6.27e-05	0.000208	CcSEcCtD
Galantamine—Convulsion—Triamcinolone—asthma	6.23e-05	0.000206	CcSEcCtD
Galantamine—Tachycardia—Prednisolone—asthma	6.23e-05	0.000206	CcSEcCtD
Galantamine—Convulsion—Methylprednisolone—asthma	6.21e-05	0.000206	CcSEcCtD
Galantamine—Hypertension—Triamcinolone—asthma	6.21e-05	0.000205	CcSEcCtD
Galantamine—Hypertension—Methylprednisolone—asthma	6.19e-05	0.000205	CcSEcCtD
Galantamine—Hyperhidrosis—Prednisolone—asthma	6.17e-05	0.000204	CcSEcCtD
Galantamine—Shock—Hydrocortisone—asthma	6.13e-05	0.000203	CcSEcCtD
Galantamine—Myalgia—Triamcinolone—asthma	6.12e-05	0.000203	CcSEcCtD
Galantamine—Nervous system disorder—Hydrocortisone—asthma	6.11e-05	0.000202	CcSEcCtD
Galantamine—Arthralgia—Methylprednisolone—asthma	6.11e-05	0.000202	CcSEcCtD
Galantamine—Myalgia—Methylprednisolone—asthma	6.11e-05	0.000202	CcSEcCtD
Galantamine—Eye disorder—Prednisone—asthma	6.1e-05	0.000202	CcSEcCtD
Galantamine—Anxiety—Methylprednisolone—asthma	6.09e-05	0.000201	CcSEcCtD
Galantamine—Tachycardia—Hydrocortisone—asthma	6.08e-05	0.000201	CcSEcCtD
Galantamine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—asthma	6.06e-05	0.000201	CcSEcCtD
Galantamine—Flushing—Prednisone—asthma	6.06e-05	0.0002	CcSEcCtD
Galantamine—Skin disorder—Hydrocortisone—asthma	6.05e-05	0.0002	CcSEcCtD
Galantamine—Ill-defined disorder—Dexamethasone—asthma	6.05e-05	0.0002	CcSEcCtD
Galantamine—Ill-defined disorder—Betamethasone—asthma	6.05e-05	0.0002	CcSEcCtD
Galantamine—Discomfort—Triamcinolone—asthma	6.05e-05	0.0002	CcSEcCtD
Galantamine—Discomfort—Methylprednisolone—asthma	6.03e-05	0.0002	CcSEcCtD
Galantamine—Hyperhidrosis—Hydrocortisone—asthma	6.02e-05	0.000199	CcSEcCtD
Galantamine—ACHE—Neuronal System—ADCY2—asthma	6.01e-05	0.000748	CbGpPWpGaD
Galantamine—Dry mouth—Triamcinolone—asthma	5.99e-05	0.000198	CcSEcCtD
Galantamine—Anorexia—Hydrocortisone—asthma	5.94e-05	0.000197	CcSEcCtD
Galantamine—Angiopathy—Prednisone—asthma	5.92e-05	0.000196	CcSEcCtD
Galantamine—Confusional state—Methylprednisolone—asthma	5.9e-05	0.000195	CcSEcCtD
Galantamine—Immune system disorder—Prednisone—asthma	5.89e-05	0.000195	CcSEcCtD
Galantamine—ACHE—Metabolism of proteins—SLC30A8—asthma	5.89e-05	0.000734	CbGpPWpGaD
Galantamine—Malaise—Betamethasone—asthma	5.88e-05	0.000195	CcSEcCtD
Galantamine—Malaise—Dexamethasone—asthma	5.88e-05	0.000195	CcSEcCtD
Galantamine—Vertigo—Betamethasone—asthma	5.86e-05	0.000194	CcSEcCtD
Galantamine—Vertigo—Dexamethasone—asthma	5.86e-05	0.000194	CcSEcCtD
Galantamine—Syncope—Dexamethasone—asthma	5.85e-05	0.000194	CcSEcCtD
Galantamine—Syncope—Betamethasone—asthma	5.85e-05	0.000194	CcSEcCtD
Galantamine—Arrhythmia—Prednisone—asthma	5.83e-05	0.000193	CcSEcCtD
Galantamine—Hypotension—Hydrocortisone—asthma	5.82e-05	0.000193	CcSEcCtD
Galantamine—CHRNB2—SIDS Susceptibility Pathways—IL6—asthma	5.79e-05	0.000721	CbGpPWpGaD
Galantamine—Shock—Triamcinolone—asthma	5.77e-05	0.000191	CcSEcCtD
Galantamine—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—asthma	5.77e-05	0.000719	CbGpPWpGaD
Galantamine—Insomnia—Prednisolone—asthma	5.77e-05	0.000191	CcSEcCtD
Galantamine—Shock—Methylprednisolone—asthma	5.76e-05	0.000191	CcSEcCtD
Galantamine—Nervous system disorder—Methylprednisolone—asthma	5.74e-05	0.00019	CcSEcCtD
Galantamine—CHRNA4—SIDS Susceptibility Pathways—CXCL8—asthma	5.74e-05	0.000715	CbGpPWpGaD
Galantamine—Loss of consciousness—Dexamethasone—asthma	5.73e-05	0.00019	CcSEcCtD
Galantamine—Loss of consciousness—Betamethasone—asthma	5.73e-05	0.00019	CcSEcCtD
Galantamine—Paraesthesia—Prednisolone—asthma	5.73e-05	0.00019	CcSEcCtD
Galantamine—Tachycardia—Triamcinolone—asthma	5.73e-05	0.00019	CcSEcCtD
Galantamine—CHRNA7—SIDS Susceptibility Pathways—VEGFA—asthma	5.72e-05	0.000713	CbGpPWpGaD
Galantamine—Mental disorder—Prednisone—asthma	5.72e-05	0.000189	CcSEcCtD
Galantamine—Tachycardia—Methylprednisolone—asthma	5.71e-05	0.000189	CcSEcCtD
Galantamine—Skin disorder—Methylprednisolone—asthma	5.69e-05	0.000188	CcSEcCtD
Galantamine—Malnutrition—Prednisone—asthma	5.68e-05	0.000188	CcSEcCtD
Galantamine—Musculoskeletal discomfort—Hydrocortisone—asthma	5.68e-05	0.000188	CcSEcCtD
Galantamine—Hyperhidrosis—Triamcinolone—asthma	5.67e-05	0.000188	CcSEcCtD
Galantamine—Hyperhidrosis—Methylprednisolone—asthma	5.66e-05	0.000187	CcSEcCtD
Galantamine—Convulsion—Betamethasone—asthma	5.65e-05	0.000187	CcSEcCtD
Galantamine—Convulsion—Dexamethasone—asthma	5.65e-05	0.000187	CcSEcCtD
Galantamine—CYP3A4—Tryptophan metabolism—CAT—asthma	5.65e-05	0.000704	CbGpPWpGaD
Galantamine—CHRNB4—SIDS Susceptibility Pathways—TNF—asthma	5.65e-05	0.000704	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—ALOX5AP—asthma	5.65e-05	0.000703	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—ALOX15—asthma	5.65e-05	0.000703	CbGpPWpGaD
Galantamine—Insomnia—Hydrocortisone—asthma	5.64e-05	0.000187	CcSEcCtD
Galantamine—Hypertension—Betamethasone—asthma	5.63e-05	0.000186	CcSEcCtD
Galantamine—Hypertension—Dexamethasone—asthma	5.63e-05	0.000186	CcSEcCtD
Galantamine—Paraesthesia—Hydrocortisone—asthma	5.59e-05	0.000185	CcSEcCtD
Galantamine—Myalgia—Betamethasone—asthma	5.55e-05	0.000184	CcSEcCtD
Galantamine—Myalgia—Dexamethasone—asthma	5.55e-05	0.000184	CcSEcCtD
Galantamine—Anxiety—Dexamethasone—asthma	5.53e-05	0.000183	CcSEcCtD
Galantamine—Anxiety—Betamethasone—asthma	5.53e-05	0.000183	CcSEcCtD
Galantamine—CHRNA4—SIDS Susceptibility Pathways—IL1B—asthma	5.51e-05	0.000686	CbGpPWpGaD
Galantamine—Discomfort—Betamethasone—asthma	5.49e-05	0.000182	CcSEcCtD
Galantamine—Discomfort—Dexamethasone—asthma	5.49e-05	0.000182	CcSEcCtD
Galantamine—Dyspepsia—Hydrocortisone—asthma	5.48e-05	0.000182	CcSEcCtD
Galantamine—Hypotension—Methylprednisolone—asthma	5.47e-05	0.000181	CcSEcCtD
Galantamine—Decreased appetite—Hydrocortisone—asthma	5.42e-05	0.000179	CcSEcCtD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—CHAT—asthma	5.39e-05	0.000671	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—PLA2G7—asthma	5.38e-05	0.000671	CbGpPWpGaD
Galantamine—Gastrointestinal disorder—Hydrocortisone—asthma	5.38e-05	0.000178	CcSEcCtD
Galantamine—Fatigue—Hydrocortisone—asthma	5.37e-05	0.000178	CcSEcCtD
Galantamine—BCHE—Neuronal System—ADCY2—asthma	5.36e-05	0.000668	CbGpPWpGaD
Galantamine—Vision blurred—Prednisone—asthma	5.35e-05	0.000177	CcSEcCtD
Galantamine—Musculoskeletal discomfort—Triamcinolone—asthma	5.34e-05	0.000177	CcSEcCtD
Galantamine—Musculoskeletal discomfort—Methylprednisolone—asthma	5.33e-05	0.000177	CcSEcCtD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—CDK2—asthma	5.32e-05	0.000662	CbGpPWpGaD
Galantamine—Insomnia—Triamcinolone—asthma	5.31e-05	0.000176	CcSEcCtD
Galantamine—Insomnia—Methylprednisolone—asthma	5.29e-05	0.000175	CcSEcCtD
Galantamine—Ill-defined disorder—Prednisone—asthma	5.27e-05	0.000174	CcSEcCtD
Galantamine—Paraesthesia—Triamcinolone—asthma	5.27e-05	0.000174	CcSEcCtD
Galantamine—Feeling abnormal—Prednisolone—asthma	5.26e-05	0.000174	CcSEcCtD
Galantamine—Paraesthesia—Methylprednisolone—asthma	5.26e-05	0.000174	CcSEcCtD
Galantamine—BCHE—Metabolism of proteins—SLC30A8—asthma	5.25e-05	0.000654	CbGpPWpGaD
Galantamine—Anaemia—Prednisone—asthma	5.25e-05	0.000174	CcSEcCtD
Galantamine—Shock—Dexamethasone—asthma	5.24e-05	0.000173	CcSEcCtD
Galantamine—Shock—Betamethasone—asthma	5.24e-05	0.000173	CcSEcCtD
Galantamine—Nervous system disorder—Dexamethasone—asthma	5.22e-05	0.000173	CcSEcCtD
Galantamine—Nervous system disorder—Betamethasone—asthma	5.22e-05	0.000173	CcSEcCtD
Galantamine—Agitation—Prednisone—asthma	5.22e-05	0.000173	CcSEcCtD
Galantamine—Thrombocytopenia—Betamethasone—asthma	5.21e-05	0.000173	CcSEcCtD
Galantamine—Thrombocytopenia—Dexamethasone—asthma	5.21e-05	0.000173	CcSEcCtD
Galantamine—Tachycardia—Dexamethasone—asthma	5.2e-05	0.000172	CcSEcCtD
Galantamine—Tachycardia—Betamethasone—asthma	5.2e-05	0.000172	CcSEcCtD
Galantamine—Dyspepsia—Triamcinolone—asthma	5.16e-05	0.000171	CcSEcCtD
Galantamine—Dyspepsia—Methylprednisolone—asthma	5.15e-05	0.000171	CcSEcCtD
Galantamine—Hyperhidrosis—Betamethasone—asthma	5.15e-05	0.00017	CcSEcCtD
Galantamine—Hyperhidrosis—Dexamethasone—asthma	5.15e-05	0.00017	CcSEcCtD
Galantamine—Feeling abnormal—Hydrocortisone—asthma	5.13e-05	0.00017	CcSEcCtD
Galantamine—Malaise—Prednisone—asthma	5.12e-05	0.00017	CcSEcCtD
Galantamine—Vertigo—Prednisone—asthma	5.1e-05	0.000169	CcSEcCtD
Galantamine—Gastrointestinal pain—Hydrocortisone—asthma	5.09e-05	0.000169	CcSEcCtD
Galantamine—Syncope—Prednisone—asthma	5.09e-05	0.000169	CcSEcCtD
Galantamine—Anorexia—Betamethasone—asthma	5.07e-05	0.000168	CcSEcCtD
Galantamine—Anorexia—Dexamethasone—asthma	5.07e-05	0.000168	CcSEcCtD
Galantamine—Fatigue—Triamcinolone—asthma	5.06e-05	0.000167	CcSEcCtD
Galantamine—Fatigue—Methylprednisolone—asthma	5.05e-05	0.000167	CcSEcCtD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—ALOX5AP—asthma	5.04e-05	0.000628	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—ALOX15—asthma	5.04e-05	0.000628	CbGpPWpGaD
Galantamine—ACHE—ATF-2 transcription factor network—IL6—asthma	5.01e-05	0.000624	CbGpPWpGaD
Galantamine—Loss of consciousness—Prednisone—asthma	4.99e-05	0.000165	CcSEcCtD
Galantamine—Hypotension—Dexamethasone—asthma	4.97e-05	0.000165	CcSEcCtD
Galantamine—Hypotension—Betamethasone—asthma	4.97e-05	0.000165	CcSEcCtD
Galantamine—Body temperature increased—Hydrocortisone—asthma	4.93e-05	0.000163	CcSEcCtD
Galantamine—Abdominal pain—Hydrocortisone—asthma	4.93e-05	0.000163	CcSEcCtD
Galantamine—Convulsion—Prednisone—asthma	4.92e-05	0.000163	CcSEcCtD
Galantamine—Hypertension—Prednisone—asthma	4.9e-05	0.000162	CcSEcCtD
Galantamine—CHRNA7—SIDS Susceptibility Pathways—TNF—asthma	4.9e-05	0.000611	CbGpPWpGaD
Galantamine—Musculoskeletal discomfort—Dexamethasone—asthma	4.85e-05	0.000161	CcSEcCtD
Galantamine—Musculoskeletal discomfort—Betamethasone—asthma	4.85e-05	0.000161	CcSEcCtD
Galantamine—Arthralgia—Prednisone—asthma	4.84e-05	0.00016	CcSEcCtD
Galantamine—Myalgia—Prednisone—asthma	4.84e-05	0.00016	CcSEcCtD
Galantamine—Feeling abnormal—Triamcinolone—asthma	4.83e-05	0.00016	CcSEcCtD
Galantamine—Feeling abnormal—Methylprednisolone—asthma	4.82e-05	0.00016	CcSEcCtD
Galantamine—Anxiety—Prednisone—asthma	4.82e-05	0.00016	CcSEcCtD
Galantamine—Insomnia—Dexamethasone—asthma	4.81e-05	0.000159	CcSEcCtD
Galantamine—Insomnia—Betamethasone—asthma	4.81e-05	0.000159	CcSEcCtD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—CHAT—asthma	4.8e-05	0.000599	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—PLA2G7—asthma	4.8e-05	0.000599	CbGpPWpGaD
Galantamine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—asthma	4.8e-05	0.000159	CcSEcCtD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—ALOX5—asthma	4.8e-05	0.000598	CbGpPWpGaD
Galantamine—Gastrointestinal pain—Methylprednisolone—asthma	4.79e-05	0.000158	CcSEcCtD
Galantamine—Paraesthesia—Betamethasone—asthma	4.78e-05	0.000158	CcSEcCtD
Galantamine—Paraesthesia—Dexamethasone—asthma	4.78e-05	0.000158	CcSEcCtD
Galantamine—Discomfort—Prednisone—asthma	4.78e-05	0.000158	CcSEcCtD
Galantamine—CHRNB2—Circadian rythm related genes—IL6—asthma	4.73e-05	0.000589	CbGpPWpGaD
Galantamine—Hypersensitivity—Prednisolone—asthma	4.7e-05	0.000156	CcSEcCtD
Galantamine—CYP2D6—Biological oxidations—ALDH2—asthma	4.69e-05	0.000584	CbGpPWpGaD
Galantamine—Dyspepsia—Dexamethasone—asthma	4.69e-05	0.000155	CcSEcCtD
Galantamine—Dyspepsia—Betamethasone—asthma	4.69e-05	0.000155	CcSEcCtD
Galantamine—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—asthma	4.66e-05	0.000581	CbGpPWpGaD
Galantamine—CHRNA4—SIDS Susceptibility Pathways—VEGFA—asthma	4.66e-05	0.000581	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—CMA1—asthma	4.65e-05	0.00058	CbGpPWpGaD
Galantamine—Body temperature increased—Triamcinolone—asthma	4.64e-05	0.000154	CcSEcCtD
Galantamine—Abdominal pain—Methylprednisolone—asthma	4.63e-05	0.000153	CcSEcCtD
Galantamine—Decreased appetite—Dexamethasone—asthma	4.63e-05	0.000153	CcSEcCtD
Galantamine—Decreased appetite—Betamethasone—asthma	4.63e-05	0.000153	CcSEcCtD
Galantamine—ACHE—Metabolism—LTC4S—asthma	4.62e-05	0.000575	CbGpPWpGaD
Galantamine—Gastrointestinal disorder—Dexamethasone—asthma	4.6e-05	0.000152	CcSEcCtD
Galantamine—Gastrointestinal disorder—Betamethasone—asthma	4.6e-05	0.000152	CcSEcCtD
Galantamine—Hypersensitivity—Hydrocortisone—asthma	4.59e-05	0.000152	CcSEcCtD
Galantamine—Fatigue—Betamethasone—asthma	4.59e-05	0.000152	CcSEcCtD
Galantamine—Fatigue—Dexamethasone—asthma	4.59e-05	0.000152	CcSEcCtD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—CARM1—asthma	4.58e-05	0.000571	CbGpPWpGaD
Galantamine—Shock—Prednisone—asthma	4.56e-05	0.000151	CcSEcCtD
Galantamine—CHRNB4—SIDS Susceptibility Pathways—IL6—asthma	4.56e-05	0.000568	CbGpPWpGaD
Galantamine—Nervous system disorder—Prednisone—asthma	4.55e-05	0.000151	CcSEcCtD
Galantamine—Tachycardia—Prednisone—asthma	4.52e-05	0.00015	CcSEcCtD
Galantamine—Skin disorder—Prednisone—asthma	4.5e-05	0.000149	CcSEcCtD
Galantamine—Hyperhidrosis—Prednisone—asthma	4.48e-05	0.000148	CcSEcCtD
Galantamine—Asthenia—Hydrocortisone—asthma	4.47e-05	0.000148	CcSEcCtD
Galantamine—CYP2D6—Biological oxidations—GSTT1—asthma	4.46e-05	0.000556	CbGpPWpGaD
Galantamine—Anorexia—Prednisone—asthma	4.42e-05	0.000146	CcSEcCtD
Galantamine—Feeling abnormal—Betamethasone—asthma	4.39e-05	0.000145	CcSEcCtD
Galantamine—Feeling abnormal—Dexamethasone—asthma	4.39e-05	0.000145	CcSEcCtD
Galantamine—Gastrointestinal pain—Betamethasone—asthma	4.35e-05	0.000144	CcSEcCtD
Galantamine—Gastrointestinal pain—Dexamethasone—asthma	4.35e-05	0.000144	CcSEcCtD
Galantamine—Hypersensitivity—Triamcinolone—asthma	4.32e-05	0.000143	CcSEcCtD
Galantamine—Hypersensitivity—Methylprednisolone—asthma	4.31e-05	0.000143	CcSEcCtD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—ALOX5—asthma	4.28e-05	0.000534	CbGpPWpGaD
Galantamine—Diarrhoea—Hydrocortisone—asthma	4.26e-05	0.000141	CcSEcCtD
Galantamine—Musculoskeletal discomfort—Prednisone—asthma	4.22e-05	0.00014	CcSEcCtD
Galantamine—Dizziness—Prednisolone—asthma	4.22e-05	0.00014	CcSEcCtD
Galantamine—Asthenia—Triamcinolone—asthma	4.21e-05	0.000139	CcSEcCtD
Galantamine—Abdominal pain—Betamethasone—asthma	4.21e-05	0.000139	CcSEcCtD
Galantamine—Abdominal pain—Dexamethasone—asthma	4.21e-05	0.000139	CcSEcCtD
Galantamine—Body temperature increased—Dexamethasone—asthma	4.21e-05	0.000139	CcSEcCtD
Galantamine—Body temperature increased—Betamethasone—asthma	4.21e-05	0.000139	CcSEcCtD
Galantamine—Asthenia—Methylprednisolone—asthma	4.2e-05	0.000139	CcSEcCtD
Galantamine—Insomnia—Prednisone—asthma	4.19e-05	0.000139	CcSEcCtD
Galantamine—Paraesthesia—Prednisone—asthma	4.16e-05	0.000138	CcSEcCtD
Galantamine—BCHE—Metabolism of proteins—CMA1—asthma	4.15e-05	0.000517	CbGpPWpGaD
Galantamine—Dizziness—Hydrocortisone—asthma	4.12e-05	0.000136	CcSEcCtD
Galantamine—BCHE—Metabolism—LTC4S—asthma	4.12e-05	0.000513	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—CARM1—asthma	4.08e-05	0.000509	CbGpPWpGaD
Galantamine—Dyspepsia—Prednisone—asthma	4.08e-05	0.000135	CcSEcCtD
Galantamine—ACHE—Phospholipid metabolism—PTEN—asthma	4.06e-05	0.000506	CbGpPWpGaD
Galantamine—Decreased appetite—Prednisone—asthma	4.03e-05	0.000133	CcSEcCtD
Galantamine—Rash—Prednisolone—asthma	4.02e-05	0.000133	CcSEcCtD
Galantamine—Dermatitis—Prednisolone—asthma	4.02e-05	0.000133	CcSEcCtD
Galantamine—Diarrhoea—Methylprednisolone—asthma	4.01e-05	0.000133	CcSEcCtD
Galantamine—ACHE—Metabolism—LTA4H—asthma	4e-05	0.000499	CbGpPWpGaD
Galantamine—Fatigue—Prednisone—asthma	4e-05	0.000132	CcSEcCtD
Galantamine—Headache—Prednisolone—asthma	4e-05	0.000132	CcSEcCtD
Galantamine—CHRNA4—SIDS Susceptibility Pathways—TNF—asthma	4e-05	0.000498	CbGpPWpGaD
Galantamine—Constipation—Prednisone—asthma	3.96e-05	0.000131	CcSEcCtD
Galantamine—Vomiting—Hydrocortisone—asthma	3.96e-05	0.000131	CcSEcCtD
Galantamine—CHRNA7—SIDS Susceptibility Pathways—IL6—asthma	3.96e-05	0.000493	CbGpPWpGaD
Galantamine—Rash—Hydrocortisone—asthma	3.93e-05	0.00013	CcSEcCtD
Galantamine—Dermatitis—Hydrocortisone—asthma	3.92e-05	0.00013	CcSEcCtD
Galantamine—Headache—Hydrocortisone—asthma	3.9e-05	0.000129	CcSEcCtD
Galantamine—Dizziness—Triamcinolone—asthma	3.88e-05	0.000128	CcSEcCtD
Galantamine—Dizziness—Methylprednisolone—asthma	3.87e-05	0.000128	CcSEcCtD
Galantamine—Feeling abnormal—Prednisone—asthma	3.82e-05	0.000126	CcSEcCtD
Galantamine—Asthenia—Betamethasone—asthma	3.82e-05	0.000126	CcSEcCtD
Galantamine—Asthenia—Dexamethasone—asthma	3.82e-05	0.000126	CcSEcCtD
Galantamine—Gastrointestinal pain—Prednisone—asthma	3.79e-05	0.000126	CcSEcCtD
Galantamine—Nausea—Prednisolone—asthma	3.79e-05	0.000125	CcSEcCtD
Galantamine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—asthma	3.78e-05	0.000471	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—BCL2—asthma	3.78e-05	0.000471	CbGpPWpGaD
Galantamine—Vomiting—Triamcinolone—asthma	3.73e-05	0.000123	CcSEcCtD
Galantamine—Vomiting—Methylprednisolone—asthma	3.72e-05	0.000123	CcSEcCtD
Galantamine—Nausea—Hydrocortisone—asthma	3.7e-05	0.000123	CcSEcCtD
Galantamine—Rash—Triamcinolone—asthma	3.7e-05	0.000122	CcSEcCtD
Galantamine—Dermatitis—Triamcinolone—asthma	3.7e-05	0.000122	CcSEcCtD
Galantamine—Rash—Methylprednisolone—asthma	3.69e-05	0.000122	CcSEcCtD
Galantamine—Dermatitis—Methylprednisolone—asthma	3.69e-05	0.000122	CcSEcCtD
Galantamine—Headache—Triamcinolone—asthma	3.68e-05	0.000122	CcSEcCtD
Galantamine—Headache—Methylprednisolone—asthma	3.67e-05	0.000121	CcSEcCtD
Galantamine—Body temperature increased—Prednisone—asthma	3.66e-05	0.000121	CcSEcCtD
Galantamine—Abdominal pain—Prednisone—asthma	3.66e-05	0.000121	CcSEcCtD
Galantamine—Diarrhoea—Betamethasone—asthma	3.64e-05	0.000121	CcSEcCtD
Galantamine—Diarrhoea—Dexamethasone—asthma	3.64e-05	0.000121	CcSEcCtD
Galantamine—BCHE—Phospholipid metabolism—PTEN—asthma	3.62e-05	0.000452	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—PTGS2—asthma	3.59e-05	0.000448	CbGpPWpGaD
Galantamine—BCHE—Metabolism—LTA4H—asthma	3.57e-05	0.000445	CbGpPWpGaD
Galantamine—Dizziness—Dexamethasone—asthma	3.52e-05	0.000117	CcSEcCtD
Galantamine—Dizziness—Betamethasone—asthma	3.52e-05	0.000117	CcSEcCtD
Galantamine—ACHE—Metabolism—ARG1—asthma	3.5e-05	0.000436	CbGpPWpGaD
Galantamine—Nausea—Triamcinolone—asthma	3.48e-05	0.000115	CcSEcCtD
Galantamine—Nausea—Methylprednisolone—asthma	3.48e-05	0.000115	CcSEcCtD
Galantamine—Hypersensitivity—Prednisone—asthma	3.42e-05	0.000113	CcSEcCtD
Galantamine—Vomiting—Dexamethasone—asthma	3.38e-05	0.000112	CcSEcCtD
Galantamine—Vomiting—Betamethasone—asthma	3.38e-05	0.000112	CcSEcCtD
Galantamine—Rash—Betamethasone—asthma	3.36e-05	0.000111	CcSEcCtD
Galantamine—Rash—Dexamethasone—asthma	3.36e-05	0.000111	CcSEcCtD
Galantamine—Dermatitis—Dexamethasone—asthma	3.35e-05	0.000111	CcSEcCtD
Galantamine—Dermatitis—Betamethasone—asthma	3.35e-05	0.000111	CcSEcCtD
Galantamine—Headache—Dexamethasone—asthma	3.33e-05	0.00011	CcSEcCtD
Galantamine—Headache—Betamethasone—asthma	3.33e-05	0.00011	CcSEcCtD
Galantamine—Asthenia—Prednisone—asthma	3.33e-05	0.00011	CcSEcCtD
Galantamine—CHRNA4—SIDS Susceptibility Pathways—IL6—asthma	3.22e-05	0.000402	CbGpPWpGaD
Galantamine—Diarrhoea—Prednisone—asthma	3.17e-05	0.000105	CcSEcCtD
Galantamine—ACHE—Metabolism—ALDH7A1—asthma	3.16e-05	0.000394	CbGpPWpGaD
Galantamine—Nausea—Betamethasone—asthma	3.16e-05	0.000105	CcSEcCtD
Galantamine—Nausea—Dexamethasone—asthma	3.16e-05	0.000105	CcSEcCtD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—PTEN—asthma	3.13e-05	0.00039	CbGpPWpGaD
Galantamine—BCHE—Metabolism—ARG1—asthma	3.12e-05	0.000389	CbGpPWpGaD
Galantamine—CYP2D6—Biological oxidations—GSTP1—asthma	3.09e-05	0.000385	CbGpPWpGaD
Galantamine—CYP3A4—Biological oxidations—ALDH2—asthma	3.07e-05	0.000382	CbGpPWpGaD
Galantamine—Dizziness—Prednisone—asthma	3.07e-05	0.000101	CcSEcCtD
Galantamine—CYP2D6—Metapathway biotransformation—GSTP1—asthma	3.05e-05	0.00038	CbGpPWpGaD
Galantamine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—asthma	3.05e-05	0.00038	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—ACE—asthma	3.04e-05	0.000379	CbGpPWpGaD
Galantamine—ACHE—Metabolism—ARG2—asthma	3.03e-05	0.000378	CbGpPWpGaD
Galantamine—Vomiting—Prednisone—asthma	2.95e-05	9.76e-05	CcSEcCtD
Galantamine—Rash—Prednisone—asthma	2.92e-05	9.68e-05	CcSEcCtD
Galantamine—Dermatitis—Prednisone—asthma	2.92e-05	9.67e-05	CcSEcCtD
Galantamine—CYP3A4—Biological oxidations—GSTT1—asthma	2.92e-05	0.000363	CbGpPWpGaD
Galantamine—Headache—Prednisone—asthma	2.9e-05	9.61e-05	CcSEcCtD
Galantamine—CYP2D6—Biological oxidations—GSTM1—asthma	2.84e-05	0.000354	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—VEGFA—asthma	2.83e-05	0.000352	CbGpPWpGaD
Galantamine—BCHE—Metabolism—ALDH7A1—asthma	2.82e-05	0.000352	CbGpPWpGaD
Galantamine—CYP2D6—Metapathway biotransformation—GSTM1—asthma	2.8e-05	0.000349	CbGpPWpGaD
Galantamine—Nausea—Prednisone—asthma	2.75e-05	9.12e-05	CcSEcCtD
Galantamine—BCHE—Metabolism of proteins—ACE—asthma	2.72e-05	0.000338	CbGpPWpGaD
Galantamine—BCHE—Metabolism—ARG2—asthma	2.71e-05	0.000337	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—PLA2G4A—asthma	2.66e-05	0.000331	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—TGFB1—asthma	2.6e-05	0.000324	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—EGFR—asthma	2.55e-05	0.000317	CbGpPWpGaD
Galantamine—ACHE—Metabolism—ALOX15—asthma	2.51e-05	0.000313	CbGpPWpGaD
Galantamine—ACHE—Metabolism—ALOX5AP—asthma	2.51e-05	0.000313	CbGpPWpGaD
Galantamine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—asthma	2.47e-05	0.000308	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—TNF—asthma	2.42e-05	0.000302	CbGpPWpGaD
Galantamine—ACHE—Metabolism—CHAT—asthma	2.4e-05	0.000299	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—PLA2G4A—asthma	2.37e-05	0.000296	CbGpPWpGaD
Galantamine—BCHE—Metabolism—ALOX15—asthma	2.24e-05	0.000279	CbGpPWpGaD
Galantamine—BCHE—Metabolism—ALOX5AP—asthma	2.24e-05	0.000279	CbGpPWpGaD
Galantamine—BCHE—Metabolism—CHAT—asthma	2.14e-05	0.000267	CbGpPWpGaD
Galantamine—ACHE—Metabolism—ALOX5—asthma	2.14e-05	0.000266	CbGpPWpGaD
Galantamine—ACHE—Metabolism—CARM1—asthma	2.04e-05	0.000254	CbGpPWpGaD
Galantamine—CYP3A4—Biological oxidations—GSTP1—asthma	2.02e-05	0.000252	CbGpPWpGaD
Galantamine—ACHE—Metabolism—DCN—asthma	2.01e-05	0.00025	CbGpPWpGaD
Galantamine—CYP2D6—Biological oxidations—POMC—asthma	2.01e-05	0.00025	CbGpPWpGaD
Galantamine—CYP3A4—Metapathway biotransformation—GSTP1—asthma	1.99e-05	0.000248	CbGpPWpGaD
Galantamine—ACHE—Metabolism—ALDH2—asthma	1.96e-05	0.000244	CbGpPWpGaD
Galantamine—BCHE—Metabolism—ALOX5—asthma	1.91e-05	0.000238	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—LTC4S—asthma	1.89e-05	0.000236	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—LEP—asthma	1.89e-05	0.000236	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—POMC—asthma	1.88e-05	0.000234	CbGpPWpGaD
Galantamine—ACHE—Metabolism—GSTT1—asthma	1.86e-05	0.000232	CbGpPWpGaD
Galantamine—CYP3A4—Biological oxidations—GSTM1—asthma	1.86e-05	0.000231	CbGpPWpGaD
Galantamine—CYP3A4—Metapathway biotransformation—GSTM1—asthma	1.83e-05	0.000228	CbGpPWpGaD
Galantamine—BCHE—Metabolism—CARM1—asthma	1.82e-05	0.000227	CbGpPWpGaD
Galantamine—BCHE—Metabolism—DCN—asthma	1.79e-05	0.000223	CbGpPWpGaD
Galantamine—BCHE—Metabolism—ALDH2—asthma	1.74e-05	0.000217	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—ALB—asthma	1.71e-05	0.000214	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—LEP—asthma	1.69e-05	0.00021	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—POMC—asthma	1.68e-05	0.000209	CbGpPWpGaD
Galantamine—BCHE—Metabolism—GSTT1—asthma	1.66e-05	0.000207	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—LTA4H—asthma	1.64e-05	0.000205	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—POMC—asthma	1.62e-05	0.000202	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—CCL2—asthma	1.59e-05	0.000198	CbGpPWpGaD
Galantamine—ACHE—Metabolism—NQO1—asthma	1.55e-05	0.000193	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—ALB—asthma	1.53e-05	0.000191	CbGpPWpGaD
Galantamine—ACHE—Metabolism—ADCY2—asthma	1.51e-05	0.000188	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—PTGS2—asthma	1.5e-05	0.000187	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—POMC—asthma	1.45e-05	0.000181	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ARG1—asthma	1.44e-05	0.000179	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—CCL2—asthma	1.42e-05	0.000177	CbGpPWpGaD
Galantamine—BCHE—Metabolism—NQO1—asthma	1.38e-05	0.000172	CbGpPWpGaD
Galantamine—BCHE—Metabolism—ADCY2—asthma	1.35e-05	0.000168	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—PTGS2—asthma	1.34e-05	0.000167	CbGpPWpGaD
Galantamine—CYP3A4—Biological oxidations—POMC—asthma	1.31e-05	0.000164	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—PTEN—asthma	1.31e-05	0.000163	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ALDH7A1—asthma	1.3e-05	0.000162	CbGpPWpGaD
Galantamine—ACHE—Metabolism—GSTP1—asthma	1.29e-05	0.000161	CbGpPWpGaD
Galantamine—ACHE—Metabolism—HMOX1—asthma	1.27e-05	0.000158	CbGpPWpGaD
Galantamine—ACHE—Metabolism—ITPR1—asthma	1.27e-05	0.000158	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—CXCL8—asthma	1.26e-05	0.000157	CbGpPWpGaD
Galantamine—ACHE—Metabolism—CAT—asthma	1.25e-05	0.000156	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ARG2—asthma	1.24e-05	0.000155	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—LTC4S—asthma	1.24e-05	0.000154	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PLA2G4A—asthma	1.18e-05	0.000148	CbGpPWpGaD
Galantamine—ACHE—Metabolism—GSTM1—asthma	1.18e-05	0.000148	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—PTEN—asthma	1.17e-05	0.000145	CbGpPWpGaD
Galantamine—BCHE—Metabolism—GSTP1—asthma	1.15e-05	0.000143	CbGpPWpGaD
Galantamine—BCHE—Metabolism—HMOX1—asthma	1.13e-05	0.000141	CbGpPWpGaD
Galantamine—BCHE—Metabolism—ITPR1—asthma	1.13e-05	0.000141	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—CXCL8—asthma	1.12e-05	0.00014	CbGpPWpGaD
Galantamine—BCHE—Metabolism—CAT—asthma	1.12e-05	0.000139	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PPP2CA—asthma	1.09e-05	0.000136	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—LTA4H—asthma	1.07e-05	0.000134	CbGpPWpGaD
Galantamine—BCHE—Metabolism—GSTM1—asthma	1.06e-05	0.000132	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PLA2G4A—asthma	1.06e-05	0.000132	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ALOX15—asthma	1.03e-05	0.000129	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ALOX5AP—asthma	1.03e-05	0.000129	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—CHAT—asthma	9.84e-06	0.000123	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PPP2CA—asthma	9.73e-06	0.000121	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ARG1—asthma	9.38e-06	0.000117	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ALOX5—asthma	8.77e-06	0.000109	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ALDH7A1—asthma	8.49e-06	0.000106	CbGpPWpGaD
Galantamine—ACHE—Metabolism—POMC—asthma	8.37e-06	0.000104	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—CARM1—asthma	8.36e-06	0.000104	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—DCN—asthma	8.24e-06	0.000103	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ARG2—asthma	8.14e-06	0.000101	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ALDH2—asthma	8.02e-06	9.99e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—ALB—asthma	7.63e-06	9.51e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—GSTT1—asthma	7.63e-06	9.51e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—POMC—asthma	7.47e-06	9.31e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—NOS3—asthma	7.3e-06	9.1e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—ALB—asthma	6.81e-06	8.49e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ALOX15—asthma	6.74e-06	8.4e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ALOX5AP—asthma	6.74e-06	8.4e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PTGS2—asthma	6.68e-06	8.32e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—NOS3—asthma	6.51e-06	8.12e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—CHAT—asthma	6.43e-06	8.02e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—NQO1—asthma	6.34e-06	7.9e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ADCY2—asthma	6.2e-06	7.73e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PTGS2—asthma	5.96e-06	7.42e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PTEN—asthma	5.82e-06	7.26e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ALOX5—asthma	5.73e-06	7.14e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—CARM1—asthma	5.47e-06	6.82e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—DCN—asthma	5.39e-06	6.72e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—GSTP1—asthma	5.29e-06	6.59e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ALDH2—asthma	5.24e-06	6.53e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—HMOX1—asthma	5.21e-06	6.5e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ITPR1—asthma	5.2e-06	6.48e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PTEN—asthma	5.2e-06	6.47e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—CAT—asthma	5.14e-06	6.41e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—GSTT1—asthma	4.99e-06	6.21e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PLA2G4A—asthma	4.86e-06	6.05e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—GSTM1—asthma	4.86e-06	6.05e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PPP2CA—asthma	4.47e-06	5.58e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—NQO1—asthma	4.14e-06	5.17e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ADCY2—asthma	4.06e-06	5.05e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—GSTP1—asthma	3.46e-06	4.31e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—POMC—asthma	3.43e-06	4.28e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—HMOX1—asthma	3.41e-06	4.25e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ITPR1—asthma	3.4e-06	4.24e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—CAT—asthma	3.36e-06	4.19e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PLA2G4A—asthma	3.18e-06	3.96e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—GSTM1—asthma	3.18e-06	3.96e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ALB—asthma	3.13e-06	3.9e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—NOS3—asthma	2.99e-06	3.73e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PPP2CA—asthma	2.93e-06	3.65e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PTGS2—asthma	2.74e-06	3.41e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PTEN—asthma	2.39e-06	2.98e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—POMC—asthma	2.25e-06	2.8e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ALB—asthma	2.05e-06	2.55e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—NOS3—asthma	1.96e-06	2.44e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PTGS2—asthma	1.79e-06	2.23e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PTEN—asthma	1.56e-06	1.95e-05	CbGpPWpGaD
